Ribonucleotide reductase based gene therapy - StemCardia
Alternative Names: Ribonucleotide-reductase-based-gene-therapy - StemCardia; RNR - StemCardiaLatest Information Update: 29 Apr 2024
At a glance
- Originator StemCardia
- Class Gene therapies; Heart failure therapies; Ribonucleotides
- Mechanism of Action Gene transference; Ribonucleotide reductase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Chronic heart failure
Most Recent Events
- 01 Apr 2024 Preclinical trials in Chronic heart failure in USA (unspecified route) (StemCardia pipeline, March 2024)